Testes less radiation after a complete response to medicines
Part of Cancer, Skin clinical trials.
This study checks whether some people with breast cancer who have no remaining cancer after medicine (neoadjuvant systemic therapy) can safely receive less radiation. It may help reduce side effects while still keeping cancer controlled.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a woman age 18 or older
- Your breast cancer is hormone receptor positive (HR+) and HER2 negative, or HER2 positive, or triple-negative
- Your initial breast tumor was small to medium (clinical stage T1–2) and it was unifocal (one main area)
- Before starting treatment, your lymph nodes looked clear (confirmed by ultrasound or FDG-PET/CT)
- You received medicines before surgery, had a marker placed in the tumor, and had breast-conserving surgery (no mastectomy)
- After treatment, scans/pathology showed complete response: no cancer cells or DCIS in the breast and lymph nodes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment plan for early breast cancer that involves at least three suspicious lymph nodes on the ultrasound/imaging. It looks at whether a targeted technique—done before surgery with chemotherapy—can improve or guide care when surgery will remove the lymph nodes.
This study looks at a less invasive way to check and treat lymph nodes in the armpit after you receive chemotherapy (and sometimes immunotherapy) before breast surgery. It may help people with cancer that has already spread to armpit lymph nodes by improving how staging and treatment are done.
This trial looks at whether some people with HER2-positive or HR-positive breast cancer can safely avoid a sentinel lymph node biopsy after chemotherapy. It tests a treatment approach based on how completely the breast tumor shrinks on MRI and whether lymph nodes look clear before treatment.
This trial tests whether giving less radiation to the lymph nodes is safe and effective for breast cancer patients whose lymph nodes were cancer-free after chemotherapy and surgery. It may mean fewer side effects for you.
This trial studies whether a specific radiation approach after lumpectomy can be helpful for certain people with early breast cancer that did not spread to lymph nodes at diagnosis. It focuses on people who finish neoadjuvant (before-surgery) treatment and reach a full response on final pathology.
This trial tests whether older women with very low-risk, hormone-positive breast cancer can safely skip endocrine therapy (hormone-blocking pills) and radiation after lumpectomy. It aims to maintain quality of life while keeping cancer from coming back.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.